Deck

Constellation Software · CSU · TSX

Canadian holding company that buys small vertical-market software businesses — roughly 140 a year — and holds them indefinitely, taking most of its revenue from recurring maintenance fees on more than a thousand niche product lines.

C$2,612
Price
C$55B
Market cap
$11.6B
Revenue FY25 (USD)
~140
VMS deals per year
Listed 2006 on the TSX. Compounded from C$533 in April 2016 to a C$5,182 close on May 8, 2025, then halved to C$2,612 in twelve months — the largest drawdown in the company's twenty-year public history.
2 · The tension

The same three-year slide in capital deployed reads as discipline to bulls and as a ceiling to bears.

  • The fact. Cash deployed into acquisitions fell three years running — $1.70B in FY23, $1.52B in FY24, $1.34B in FY25, down 12% YoY — while cash on the balance sheet rose 56% from $2.0B to $3.1B over the same window.
  • The bear read. The VMS pipeline is full at acceptable prices, the IRR engine is taxing out at $11.6B of revenue, and the $260M FY25 fair-value reversal on Topicus's 23% Asseco stake (recorded when the holding crossed the 20% equity-method threshold) reads as the company itself flagging difficulty deploying wholly-owned capital at hurdle rates.
  • The bull read. Q1 FY26 already deployed $766M plus another $627M of post-quarter acquisition commitments — $1.39B inside 90 days, a single-quarter pace above all of FY25 — at multiples management says remain below 1.5× revenue.
Both camps converge on the same resolving signal: rolling four-quarter capital deployed over FY26.
3 · Money picture

FCF compounds at 21% a year over a decade while the multiple sits at a five-year low.

$2.66B
Free cash flow FY25 +25% YoY
$126
FCF per share FY25 from $18 in 2015
~15×
P/FCF spot lowest in 5 years
21.19M
Shares outstanding frozen since 2007

Share count has not moved in 18 years. Maintenance revenue is 75% of the top line, grew about 5% organic through the AI panic, and renews near 100%. The reset is multiple compression, not cash compression — at current prices CSU trades cheaper than Tyler and Jack Henry, in line with its own Lumine spinoff, and at a modest premium to Roper and the Topicus spinoff (which sit even lower on P/FCF after their own drawdowns).

4 · What changed

Leonard's 2021 letter retired the hurdle-rate doctrine that built the company — and he leaves the board this month.

Before. From the 1995 founding through 2020 Constellation deployed roughly $200M a year into ~70 vertical-software businesses at strict hurdle rates and a $10M average ticket. Maintenance economics were sacred, payback periods non-negotiable, minority stakes never happened.

Pivot. On February 15, 2021, Mark Leonard's President's Letter declared “I have stopped arguing. I have converted, and with the fervour of the newly converted.” Within 24 months CSU closed Altera at $725M, Optimal Blue at $700M, WideOrbit at $500M, took (through Topicus) a 23% stake in Warsaw-listed Asseco Poland, and stopped publishing President's Letters altogether.

Today. ROIC has compressed from a 19–21% peak (2017–2020) to 11.7% in FY25. Leonard did not stand for re-election at the May 15, 2026 AGM. President Mark Miller drew his last paycheque in December 2025 — he waived salary and bonus from January 1, 2026 onward. The next chapter answers whether the system survives its author.

From rules-based discipline to discretion-based capital allocation — the central change the market is repricing.
5 · The control group

Topicus and Lumine run the same compensation system with no Leonard involvement — both compound.

  • Topicus (spun Feb 2021). FY25 revenue +19.9%, organic +9%, FCF margin 25.9%. Five years operating independently on the European VMS playbook with the identical no-options compensation rule — after-tax bonuses funneled into open-market share purchases held four years. After its own drawdown it now trades at roughly 11–12× P/FCF on current market cap versus FY25 FCF (16.4× at the FY-end share price).
  • Lumine (spun Feb 2023). FY25 revenue +14.6% (44% three-year CAGR), FCF margin 30.3%, ROIC 14%. Three years on the telecom and media verticals under the same governance template. Trades at roughly 16× P/FCF on current market cap versus FY25 FCF (21.8× at the FY-end share price).
  • The implication. The market discounts CSU below both spinoffs for founder dependency, yet the spinoffs are the live proof the model travels without Leonard. Combined FY25 capital deployment at TOI plus LMN was roughly $300M (TOI $283M, LMN $14M) — a small share of the broader VMS funnel CSU once worked alone.
The succession risk is already being tested in two listed labs.
6 · Bull & Bear

The operating case holds; the doctrine case is not yet falsified — the deployment tape decides the next leg.

  • For. Cheapest multiple in five years (~15× P/FCF) on a business that grew FCF 25% in FY25 and FCF per share 21% a year for a decade with zero dilution and clean books (forensic risk 27/100).
  • For. Q1 FY26 deal cadence ($1.39B inside 90 days, including subsequent commitments — the strongest single-quarter pace in over a year) directly contradicts the deployment-ceiling narrative — though one quarter does not yet make a trend.
  • Against. ROIC has compressed from a 19–21% peak to 11.7%; the PEMS (Permanent Engaged Minority Shareholder) pivot — Topicus's 23% Asseco stake, the new Sabre position — is doctrine drift the market correctly resists paying premium multiples for. The separate $1.23B Joday IRGA put liability is a legacy Topicus-governance obligation, not a PEMS investment, but it reinforces the impression of an unusually complex capital structure.
  • Against. Largest drawdown in 20 years of public history, death cross confirmed September 8, 2025, founder leaves the board May 15, 2026, and 5-year TSR (+106%) lagged the S&P/TSX (+111%) for the first time in years.
Constructive on the cash engine while the evidence holds. The view turns cautious if FY26 cumulative deployment lands below $1.3B with cash building past $3.5B, or if Miller announces a $1B-plus non-VMS deal.

Watchlist to re-rate: Rolling four-quarter capital deployed and acquisition multiples paid; Topicus and Lumine organic growth as the live control group; any further PEMS minority stake or non-VMS pivot under Miller.